[Press Release] Hawthorne Health and RxE2 Partner to Expand Patient Access in Clinical Trials

WALNUT CREEK, CA. & FARGO, ND, January 30, 2025  Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial services, have announced a strategic partnership to transform community-based clinical trial delivery. By combining Hawthorne Health’s GCP-trained nurse network with RxE2’s integration of community pharmacists, the partnership creates the largest…

Meet our team at SCOPE 2025!

Our team will be at SCOPE 2025 in Florida, February 3 – 6. Our CEO, Gerald, will taking part in a panel titled ‘Bridging the Last Mile: A Hybrid Approach to Patient Access and Retention’, together with our partners at Hawthorne Health and with LabCorp. The Panel will take place on Wednesday, February 5.  …

Meet our CEO at PharmSci360 in Florida!

Join our session RxE2 CEO, Gerald Finken, will be taking part in a panel titled: “The Integration of Clinical Trials and Clinical Care: A Revolution in the Participant and Sponsor Experience or an Implementation Nightmare? Or Both?” When & Where Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West Meet…

Meet RxE2 at GCSG2023!

Meet us at GCSG 2023!

RxE2 is disrupting the clinical supply chain to improve quality and eliminate waste – Meet us at #GCSG2023! Current supply chain logistics provide ample opportunity for risk and waste. What if we eliminate that? Led by Gerald E. Finken, the inventor of On-Demand Packaging & Labeling, RxE2 is de-risking the process by eliminating unnecessary steps for truly patient centric…

Meet RxE2 in San Francisco!

Our team will be in San Francisco during the J.P. Morgan Healthcare Conference and is ready to meet with investors and industry leaders. We will also be taking part in the First Analysis Healthcare Technology Conference – 2023. Reach out to  Gerald Finken or to David Stark to schedule a meeting!